ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1)
HQ: ES
Founded: 2018
Series B
Sector: Biotechnology
Investment Raised: EUR 42M €
Valuation Remains Undisclosed
Investors: AdBio partners (https://adbio.partners/) Centre for the Development of Industrial Technology (CDTI) (https://www.cdti.es/) Columbus Venture Partners (https://columbusvp.com/) European Innovation Council (https://eic.ec.europa.eu/) Hadean Ventures (https://hadeanventures.com/) Invivo Capital Partners (https://invivo.capital/) Sound Bioventures (https://soundbioventures.com/)
AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain
HQ: FR
Founded: 2018
Series B
Sector: Biotechnology
Investment Raised: EUR 20M €
Valuation Remains Undisclosed
Investors: Bpifrance (https://www.bpifrance.com/) InnoBio Fund (https://www.bpifrance.com/products/biotech-and-medtech-vc-funds/) Omnes Capital (https://www.omnescapital.com/) Turenne Capital (https://www.turennecapital.com/) UI Investissement (https://www.ui-investissement.com/)
Hemab Therapeutics Raises $13.5M in Series B Financing
HQ: DK
Founded: 2017
Series B
Sector: Biotechnology
Investment Raised: USD 13M €
Valuation Remains Undisclosed
Investors: Access Biotechnology (http://accessbio-tech.com/) Avoro Ventures (https://avorocapital.com/) Deep Track Capital (https://www.deeptrackcapital.com/) HealthCap (https://www.healthcap.eu/) Invus (https://www.invus.com/who-we-are/) Maj Invest Equity (https://majinvest.com/en/) Novo Holdings (https://www.novoholdings.dk/) RA Capital Management (https://www.racap.com/) Rock Springs Capital (https://whalewisdom.com/filer/casdin-capital-llc)
NeoPhore completes extension to Series B financing of £6m to further advance discovery pipeline
HQ: UK
Founded: 2017
Series B
Sector: Biotechnology
Investment Raised: GBP 6M €
Valuation Remains Undisclosed
Investors: 2invest (https://2invest-ag.com/) 3B Future Health Fund (https://3bfuturehealth.com/) Astellas Venture Management (https://www.astellasventure.com/) Claris Ventures (http://www.clarisventures.com/) Sixth Element Capital (https://www.sixthelementcapital.com/)
STORM Therapeutics announces closing of USD $30M Series B financing
HQ: UK
Founded: 2015
Series B
Sector: Biotechnology
Investment Raised: USD 30M €
Valuation Remains Undisclosed
Investors: Cambridge Innovation Capital (https://www.cic.vc/) Fast Track Initiative IP Group (https://www.ipgroupplc.com/) M Ventures (https://www.m-ventures.com/en) Pfizer Venture Investments (https://www.pfizer.com/about/partners/venture-investments) Seroba Life Sciences (https://seroba-lifesciences.com/) Taiho Ventures (https://taihoventures.com/) UTokyo Innovation Platform (https://www.utokyo-ipc.co.jp/en/)
Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole
HQ: UK
Founded: 2013
Series C
Sector: Biotechnology
Investment Raised: USD 52M €
Valuation Remains Undisclosed
Investors: Adjuvant Capital (https://adjuvantcapital.com/) Asahi Kasei Pharma (https://www.asahikasei-pharma.co.jp/en/) Cystic Fibrosis Foundation (https://www.cff.org/) F-Prime Capital (https://fprimecapital.com/) IP Group (https://www.ipgroupplc.com/) Jeito Capital (https://www.jeito.life/en/home/) Johnson & Johnson Innovation @ JJDC (https://jnjinnovation.com/venture-investing-jjdc) Longwood Fund (https://www.longwoodfund.com/) Pictet Alternative Advisors (https://www.pictet.com/ch/en/alternative-investments) SR One (https://www.srone.com/) SV Health Investors (https://svhealthinvestors.com/) Vivo Capital (https://vivocapital.com/)
Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform
HQ: HU
Founded: 2015
Series A
Sector: Biotechnology
Investment Raised: EUR 20M €
Valuation Remains Undisclosed
Investors: Accel (https://www.accel.com/) Day One Capital (https://www.dayonecapital.com/) Delin Ventures (https://www.delinventures.com/) Mercia Fund Managers (https://www.mercia.co.uk/) Merck Global Health Innovation Fund (https://www.merckghifund.com/) XTX Ventures (https://www.xtxmarkets.com/ventures/)
Neoplants has raised more than $20 million in funding
HQ: FR
Founded: 2018
Seed
Sector: Biotechnology
Investment Raised: USD 20M €
Valuation Remains Undisclosed
Investors: Collaborative Fund (https://collabfund.com/) Entrepreneur First (https://www.joinef.com/) Heartcore Capital (https://www.heartcore.com/) Niklas Zennström True Ventures (https://trueventures.com/)
